Charles E. Mahan

Venous thromboembolism: Annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates

Matthew E. Borrego, Alex L. Woersching, Robert Federici et al. · Thrombosis and Haemostasis · 2012 · 170 citations

Medicine, Health Services Administration, Pharmacoeconomics +15

European Union-28: An annualised cost-of-illness model for venous thromboembolism

Stefano Barco, Alex L. Woersching, Alex C. Spyropoulos et al. · Thrombosis and Haemostasis · 2015 · 150 citations

Pharmacy, Economics, Pharmacoeconomics +17

Anticoagulant Reversal Strategies in the Emergency Department Setting: Recommendations of a Multidisciplinary Expert Panel

Christopher W. Baugh, Michael P. Levine, David Cornutt et al. · Annals of Emergency Medicine · 2019 · 91 citations · Full text

Medicine, Emergency Medicine, Pharmacotherapy +12

External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR)

Charles E. Mahan, Yang Liu, A. Graham Turpie et al. · Thrombosis and Haemostasis · 2014 · 84 citations

Medicine, Internal Medicine, Clinical Epidemiology +16

Deep-vein thrombosis: A United States cost model for a preventable and costly adverse event

Mark T. Holdsworth, Shawn M. Welch, Matt Borrego et al. · Thrombosis and Haemostasis · 2011 · 74 citations

Pharmacy, Pharmacoeconomics, Cost-effectiveness Analysis +16